Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men
Trevor A. Mori(The University of Western Australia), Lawrence J. Beilin(University of Western Australia), James D. Best(St Vincent's Hospital), Gerald F. Watts(The University of Western Australia), Valerie Burke(St Vincent's Hospital Melbourne), David N. O’Neal(St Vincent's Hospital Melbourne), Ian B. Puddey(St Vincent's Hospital Melbourne)
Cited by 586
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k